NEW YORK (GenomeWeb) – Horizon Discovery Group and Abcam today announced a licensing and supply agreement that gives Abcam exclusive access to more than 1,800 human diploid and haploid cell lines from Horizon's X-MAN collection. 

The cell lines will help in the validation of Abcam's existing monoclonal and polyclonal antibodies marketed to researchers, the firms said, and Horizon will develop additional haploid cell lines to validate new antibodies from Abcam. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.